Israel's leading law firm

Recent transaction and litigation

Home > Media Center > Recent transaction and litigation > 2021 > Representation of Venus Medtech (Hangzhou) Inc. in its acquisition of Cardiovalve for the total amount of $300 million
2021 / December 2021

Representation of Venus Medtech (Hangzhou) Inc. in its acquisition of Cardiovalve for the total amount of $300 million

Join our newsletter careers Contact us